002399.SZ
海普瑞
SZSE · Healthcare · C 制造业 · CN
CNY 10.00
−4.49%Year over year
Reported trailing growth
- Revenue
- +2.1%
- EBITDA
- —
- EBIT
- -39.4%
- EPS
- -41.3%
- Free cash flow
- -13.7%
- Operating cash flow
- -16.8%
Forward estimates
Based on analyst estimates
- Revenue
- -23.5%
- EBITDA
- -4.3%
- EPS
- +19.6%
Three-year CAGR
- Revenue
- -8.5%
- EBITDA
- -12.0%
- EBIT
- -20.9%
- Net income
- -21.7%
- EPS
- -21.7%
- Free cash flow
- -20.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026